In the present study, Gal-3, an inflammatory marker (1) was significantly higher in non-CAD compared to CAD patients, and in ACS compared to CCS patients with a good discriminatory capacity, (2) correlated positively with coronary stenosis severity, and (3) was associated with increased carotid and femoral plaque thickness. The gene discussed is LGALS3; the disease is coronary artery disorder.